Form EFFECT bioAffinity Technologies
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 5, 2024 |
| Accession Number: | 0001493152-24-013245 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year
- Speaker Junkies Are Back With “Super DUPR,” a High-Energy EDM Anthem For the Clubs and Pickleball Courts
- FRC's Tony Perkins on Lindsey Graham's Passing: He Embodied Moral Courage
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
